News | News By Subject | News by Disease News By Date | Search News

Allergies (misc) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
BioPharm Executive: Ok, So It's Hillary     10/28/2016
5 Myths About Mylan (MYL)'s EpiPen Scandal     9/9/2016
Backlash Leads Mylan (MYL) to Launch First Generic EpiPen at Half the Price     8/29/2016
Facing Public Backlash and Pressure from Clinton, Mylan (MYL) Caves and Lowers Price of EpiPen     8/26/2016
Outrage Ensues After Mylan (MYL) Raises EpiPen Price by 400%     8/24/2016
Merck & Co. (MRK) to Terminate Allergy Agreement With ALK-Abello A/S     7/27/2016
Allergy Therapeutics Phase II Fails to Find Hay Fever Therapy Dose Range     6/27/2016
Circassia (CIR.L) Stock Crashes as Allergy Drug Flunks Crucial Phase III Study     6/20/2016
Ocular Therapeutix (OCUL)'s Pink Eye Treatment Dextenza Flunks Phase III Test     6/6/2016
Rubius Therapeutics Springs Out of Flagship VentureLabs to Take on PKU with Red Cell Therapeutics     12/9/2015
Sanofi (SNY) May Suffer a $109 Million Hit from Injector Recall     10/29/2015
Astellas (ALPMY), Immunomic Forge $300 Million+ LAMP-vax Pact     10/9/2015
DBV Tech Nabs FDA Breakthrough Status for Peanut Allergy Patch     4/13/2015
Adamis (ADMP) Plummets More Than 30% After FDA Rejects Its Allergy Shot Application     4/1/2015
GlaxoSmithKline (GSK) Down Slightly After Johnson & Johnson (JNJ) Allergy Ad Settlement     3/31/2015

News from Around the Web
Novel Platform Uses Nanoparticles To Detect Peanut Allergies, University of Notre Dame Study     6/27/2017
Why Mylan (MYL)'s EpiPen Reign Could Finally be Over     6/16/2017
Mylan (MYL) Expands EpiPen Recall To The U.S.     4/3/2017
Mylan (MYL) Recalls 81,000 EpiPens Overseas After Reports of Failure     3/23/2017
Mylan (MYL) Faces Federal Antitrust Investigator In EpiPen Business     1/31/2017
Mylan (MYL) CEO Hopes EpiPen Furor Leads To "Price Transparency"     12/5/2016
Mylan (MYL) CEO Bresch Admits "Full Responsibility" For EpiPen Price Hikes     12/2/2016
Are Food Allergies On The Rise? Experts Say They Don't Know     12/1/2016
Meet The Woman Who Is Allergic To Everything - Including Her Husband     11/21/2016
A Pill May Soon Replace Mylan (MYL)'s Costly EpiPen     11/21/2016
PRECISION Results Open The Door For OTC Celebrex     11/15/2016
There's A Patch That Could Fix Your Peanut Allergy Problem, DBV Tech Reveals     11/2/2016
The First Peanut Allergy Therapy Might Soon Hit The Shelves, DBV Tech Reveals     10/26/2016
Health Officials Should Reject Latest Gambit By EpiPen Maker To Feed At The Public Trough     10/18/2016
Mylan (MYL) Stock Rises -- Is There A Light At The End Of The Tunnel?     10/11/2016

Press Releases
Successful Phase III Trial For ALK-Abello A/S’s Tree Allergy SLIT-Tablet     9/14/2017
SmartPractice's T.R.U.E. Ready-To-Use Patch Test Wins FDA Approval for Pediatric Use     9/12/2017
New Data Shows Previously Allergic Children Still Able To Tolerate Peanut Four Years After Treatment With A Novel Immunotherapy Licensed By Prota Therapeutics     8/17/2017
Aimmune (AIMT)’ Investigational Treatment For Peanut Allergy Featured In Science Translational Medicine Publication On Discovery Of New TH2 Cell Subset Specific To Allergy     8/8/2017
DBV Tech Initiates Phase III Study Of Viaskin Peanut In Peanut-Allergic Patients One To Three Years Of Age     8/2/2017
Acella Pharmaceuticals, LLC, Announces Approval Of Generic To Vituz Oral Solution     7/27/2017
Aimmune (AIMT) Enrolls First Patient In ARTEMIS (ARC010) European Phase III Clinical Trial Of AR101 For The Treatment Of Peanut Allergy     7/5/2017
Novartis AG (NVS) Real World Study Shows Almost Half Of Chronic Urticaria Patients Are Not Receiving Any Treatment Despite Significant Disease Burden     6/20/2017
Xencor Presents Interim Data From An Ongoing, Open-Label, Phase II Study of XmAb5871 In Igg4-Related Disease At EULAR 2017     6/16/2017
Aldeyra (ALDX) Plummets As Eye Drug Misses Primary Endpoint In Phase IIb Test     6/14/2017
Aimmune (AIMT) Reports On Up-Dosing In Its Ongoing Phase III PALISADE Trial Of AR101 For Peanut Allergy     6/13/2017
Bay Area's Aimmune (AIMT) Opens Up Shop In Florida For Potential Launch Of Its Peanut Allergy Drug     6/7/2017
Neogen Corporation (NEOG) Launches Sesame Food Allergen Test Kit     6/5/2017
Circassia (CIR.L) Finally Throws In The Towel On Allergy Program After Trial Failures     4/18/2017
Sanofi (SNY) Announces Results Of First-Of-Its-Kind Social Experiment Revealing Real-Life Impact Of Symptoms On Allergy Sufferers In The U.S.     3/21/2017

//-->